| Identification | Back Directory | [Name]
compound 351 A | [CAS]
92234-10-1 | [Synonyms]
351A
compound 351 A
N2-[(S)-1-Carboxy-3-phenylpropyl]-N6-[(4-hydroxyphenyl)iminomethyl]-L-Lys-L-Pro-OH
(S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)-6-(N'-(4-hydroxyphenyl)formimidamido)hexanoyl)pyrrolidine-2-carboxylic acid | [Molecular Formula]
C28H36N4O6 | [MOL File]
92234-10-1.mol | [Molecular Weight]
524.609 |
| Hazard Information | Back Directory | [Definition]
ChEBI: MK 351A is a member of the class of formamidines that is lisinopril in which the primary amino group is substituted by an {(E)-[(4-hydroxyphenyl)imino]methyl}amino group. It is a potent ACE inhibitor. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor. It is a member of phenols, a member of benzenes, a dicarboxylic acid, a tertiary carboxamide and a member of formamidines. It is functionally related to a lisinopril. |
|
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
|